HIGHLIGHTS
- who: Kim L. Clar et al. from the Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany have published the article: Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL, in the Journal: Cancers 2019, x of 21/09/2017
- what: The authors report that upon activation which reportedly occurs following interaction with cancer cells platelets upregulate the TNF family member Comparative analysis of the expression of RANK among different NK cell subsets and on platelets in cancer patients and healthy volunteers revealed a distinct malignant phenotype and was found to inhibit . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.